LQDA / Liquidia Corporation to Present at 22nd Annual Needham Virtual Healthcare Conference

Liquidia Technologies, Inc. (LQDA) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.17. This comp more_horizontal

MORRISVILLE, N.C., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its second quarter 2023 f more_horizontal

Liquidia (LQDA) signs an exclusive licensing agreement with Pharmosa to jointly develop and commercialize PAH and PH-ILD treatment candidate, L606, in more_horizontal

Liquidia Corporation (NASDAQ:LQDA ) Q1 2023 Results Conference Call May 4, 2023 8:30 AM ET Company Participants Jason Adair - SVP, Corporate Developme more_horizontal

MORRISVILLE, N.C., April 11, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Mr. Michael Kaseta, Chief Financial Off more_horizontal

Liquidia Corporation (NASDAQ:LQDA ) Q4 2022 Earnings Conference Call March 16, 2023 8:30 AM ET Company Participants Jason Adair - SVP, Corporate Devel more_horizontal

Liquidia Technologies, Inc. (LQDA) delivered earnings and revenue surprises of 47.06% and 46.73%, respectively, for the quarter ended December 2022. D more_horizontal

MORRISVILLE, N.C., March 09, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its full year 2022 finan more_horizontal